Question 1

What is the catalog number for CPCCOEt ((E) -Ethyl 1,1a,7,7a-tetrahydro-7- (hydroxyimino) cyclopropa[b]chromene-1a-carboxylate, mGlu1 Antagonist, CPCCOEt)?

Accepted Answer

The catalog number for CPCCOEt ((E) -Ethyl 1,1a,7,7a-tetrahydro-7- (hydroxyimino) cyclopropa[b]chromene-1a-carboxylate, mGlu1 Antagonist, CPCCOEt) is 217283.

Question 2

What sizes are available for CPCCOEt ((E) -Ethyl 1,1a,7,7a-tetrahydro-7- (hydroxyimino) cyclopropa[b]chromene-1a-carboxylate, mGlu1 Antagonist, CPCCOEt)?

Accepted Answer

CPCCOEt ((E) -Ethyl 1,1a,7,7a-tetrahydro-7- (hydroxyimino) cyclopropa[b]chromene-1a-carboxylate, mGlu1 Antagonist, CPCCOEt) is available in the following size(s): 5 mg.

Question 3

Is CPCCOEt ((E) -Ethyl 1,1a,7,7a-tetrahydro-7- (hydroxyimino) cyclopropa[b]chromene-1a-carboxylate, mGlu1 Antagonist, CPCCOEt) in stock?

Accepted Answer

CPCCOEt ((E) -Ethyl 1,1a,7,7a-tetrahydro-7- (hydroxyimino) cyclopropa[b]chromene-1a-carboxylate, mGlu1 Antagonist, CPCCOEt)

Selected Variant

217283

Size: 5 mg

Product Specifications

No additional specifications available.

Question 4

Do you offer custom or private-label production of this type of product?

Accepted Answer

Yes, custom antibody development and private-label production services are available. Contact our sales team to discuss your target, timeline, and quantity requirements.

Question 5

What is the immunogen used to generate this antibody?

Accepted Answer

Immunogen or antigen details used to raise this antibody are listed on the product datasheet under immunogen information.

Question 6

What is the recommended positive control for this assay?

Accepted Answer

A recommended positive control, where one is specified by the manufacturer, is listed on the datasheet or in the assay protocol.

CPCCOEt ((E) -Ethyl 1,1a,7,7a-tetrahydro-7- (hydroxyimino) cyclopropa[b]chromene-1a-carboxylate, mGlu1 Antagonist, CPCCOEt)

Product Specifications

Frequently Asked Questions

Explore Other Products

Luteinizing Hormone beta (LH beta) (LHb/1214), CF405S conjugate, 0.1mg/mL

Villin (GI-Mucosal & Urogenital Brush Border Marker) (VIL1/2376), CF640R conjugate, 0.1mg/mL

Cathepsin K (Marker of Tumor Invasiveness) (CTSK/2791), 1mg/mL

Anti-TRAF6 Rabbit Monoclonal Antibody

CD61 / Integrin 3 / Platelet Glycoprotein IIIa (Platelet Marker) (ITGB3/2166R), CF647 conjugate, 0.1mg/mL

CD71 / Transferrin Receptor (TFRC) (Extracellular Domain) (TFRC/1839), CF568 conjugate, 0.1mg/mL